SMTL ID : 6ovc.1

hMcl1 inhibitor complex

Coordinates

PDB Format Compare

Method

SOLUTION NMR

Oligo State

monomer

Ligands

1 x N8J: (2S)-N-(benzylsulfonyl)-4-(cyclobutylmethyl)-2-(2,4-dichlorophenyl)-3,4-dihydro-2H-1,4-benzoxazine-6-carboxamide(Non-covalent)

N8J.1: 13 residues within 4Å: Chain A: H.55, A.58, M.62, L.66, L.77, V.80, M.81, V.84, R.94, I.95, T.97, L.98, F.101 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.80, A:V.84, A:L.98, A:F.101 Hydrogen bonds: A:R.94, A:T.97 pi-Stacking: A:H.55

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Caenepeel, S. et al., AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov (2018)

Release Date

2019-05-22

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Induced myeloid leukemia cell differentiation protein Mcl-1

Related Entries With Identical Sequence